The dsRNA protein kinase PKR: virus and cell control.
暂无分享,去创建一个
E. Meurs | M. Esteban | M. A. García | M A García | M Esteban | E F Meurs | María García
[1] R. Jackson,et al. Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis , 1977, Cell.
[2] B. Williams,et al. Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.
[3] G. Squadrito,et al. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long‐lasting response to interferon therapy in patients with HCV‐1b chronic hepatitis? , 2002, Journal of viral hepatitis.
[4] T. Hunt,et al. Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Silverman,et al. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. , 1994, Science.
[6] L. Montagnier,et al. Efficiency of poly(A).poly(U) as an adjuvant. , 1988, Immunology today.
[7] N. Sonenberg,et al. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs , 2004, The EMBO journal.
[8] N. Sonenberg,et al. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. , 1995, Oncogene.
[9] M. W. Taylor,et al. Effect of Viral Double-Stranded RNA on Mammalian Cells in Culture: Cytotoxicity Under Conditions Preventing Viral Replication and Protein Synthesis , 1973, Journal of virology.
[10] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[11] A. Helenius,et al. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. , 2005, Virology.
[12] D. Faller,et al. Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras-transformed cells. , 1994, Biochimie.
[13] I. Kerr,et al. The (2'-5') oligoadenylate (pppA2'-5'A2'-5'A) synthetase and protein kinase(s) from interferon-treated cells. , 1979, European journal of biochemistry.
[14] J. Squire,et al. Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. , 1993, Genomics.
[15] N. Sonenberg,et al. Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: A novel translational control mechanism , 1989, Cell.
[16] T. Mak,et al. Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.
[17] H. Atkins,et al. Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.
[18] B. Williams,et al. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.
[19] M. Green,et al. c-Myc Is a Major Mediator of the Synergistic Growth Inhibitory Effects of Retinoic Acid and Interferon in Breast Cancer Cells* , 1998, The Journal of Biological Chemistry.
[20] C. Rivas,et al. African Swine Fever Virus GeneA179L,a Viral Homologue ofbcl-2, Protects Cells from Programmed Cell Death , 1996 .
[21] M. Gross,et al. The Herpes Simplex Virus Type 1 US11 Protein Interacts with Protein Kinase R in Infected Cells and Requires a 30-Amino-Acid Sequence Adjacent to a Kinase Substrate Domain , 2002, Journal of Virology.
[22] M. Katze,et al. P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress. , 2002, Biochemistry.
[23] P. Duesberg,et al. Double-stranded RNA in Vaccinia Virus Infected Cells , 1969, Nature.
[24] P. Lengyel,et al. The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.
[25] M. Esteban,et al. In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein p67. , 2000, Biochemistry.
[26] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[27] R. Kaufman,et al. Phosphorylation of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis in Response to Activation of the Double-stranded RNA-dependent Protein Kinase* , 1998, The Journal of Biological Chemistry.
[28] Á. Zaballos,et al. Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells , 2006, Journal of Biological Chemistry.
[29] S. B. Lee,et al. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[30] R. Kobayashi,et al. The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR* , 1997, The Journal of Biological Chemistry.
[31] Susana Guerra,et al. Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L , 2002, Oncogene.
[32] Ryuji Fukuda,et al. Mutant Influenza Viruses with a Defective NS1 Protein Cannot Block the Activation of PKR in Infected Cells , 1999, Journal of Virology.
[33] M. Clemens,et al. PKR--a protein kinase regulated by double-stranded RNA. , 1997, The international journal of biochemistry & cell biology.
[34] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.
[35] M J Clemens,et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. , 1993, Nucleic acids research.
[36] Qing-Rong Liu,et al. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.
[37] B. Williams,et al. PKR; a sentinel kinase for cellular stress , 1999, Oncogene.
[38] Ronit Vogt Sionov,et al. The cellular response to p53: the decision between life and death , 1999, Oncogene.
[39] N. Enomoto,et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.
[40] H. Yoon,et al. Molecular and structural characterization of the domain 2 of hepatitis C virus non-structural protein 5A. , 2006, Molecules and cells.
[41] K. Hunt,et al. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo , 2005, Molecular Cancer Therapeutics.
[42] Raymond Kaempfer,et al. Human Interferon-γ mRNA Autoregulates Its Translation through a Pseudoknot that Activates the Interferon-Inducible Protein Kinase PKR , 2002, Cell.
[43] R. Kaufman,et al. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] I. Kerr,et al. Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment , 1974, Nature.
[45] S. Der,et al. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[47] B. Jacobs,et al. Both Carboxy- and Amino-Terminal Domains of the Vaccinia Virus Interferon Resistance Gene, E3L, Are Required for Pathogenesis in a Mouse Model , 2001, Journal of Virology.
[48] N. Sonenberg,et al. Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.
[49] M. Mathews,et al. The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR. , 2002, Nucleic acids research.
[50] B. Berkhout,et al. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. , 1991, Science.
[51] A. Laurent,et al. Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Esteban,et al. Activation of NF-κB by the dsRNA-dependent protein kinase, PKR involves the IκB kinase complex , 2000, Oncogene.
[53] J. Hershey,et al. Translational control in mammalian cells. , 1991, Annual review of biochemistry.
[54] G. Stark,et al. A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[55] A. Lau,et al. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] T. Takizawa,et al. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection , 1996, Journal of virology.
[57] M. Karin,et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.
[58] T. Terada,et al. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma. , 2000, Liver.
[59] J. Howard,et al. Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response , 2005, Journal of Virology.
[60] R. Krug,et al. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. , 2006, Virology.
[61] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[62] Michael G. Katze,et al. Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.
[63] M. Esteban,et al. Interferon inhibits Viral Protein Synthesis in L Cells infected with Vaccinia Virus , 1972, Nature.
[64] Anne Gatignol,et al. TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencing , 2005, EMBO reports.
[65] A. Cuddihy,et al. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro , 1999, Oncogene.
[66] M. Mathews,et al. Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Langland,et al. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells , 1997, Journal of virology.
[68] A. Hovanessian,et al. Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.
[69] M. Katze,et al. PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. , 1993, Journal of interferon research.
[70] R. Rhoads. Regulation of eukaryotic protein synthesis by initiation factors. , 1993, The Journal of biological chemistry.
[71] A. Koromilas,et al. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[72] B. Jacobs,et al. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. , 1997, Virology.
[73] C. Samuel,et al. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.
[74] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[75] M. Lai,et al. Detection of a Novel Unglycosylated Form of Hepatitis C Virus E2 Envelope Protein That Is Located in the Cytosol and Interacts with PKR , 2002, Journal of Virology.
[76] A. Hinnebusch,et al. Binding of Double-stranded RNA to Protein Kinase PKR Is Required for Dimerization and Promotes Critical Autophosphorylation Events in the Activation Loop* , 2001, The Journal of Biological Chemistry.
[77] Mingli Yang,et al. RAX, a Cellular Activator for Double-stranded RNA-dependent Protein Kinase during Stress Signaling* , 1999, The Journal of Biological Chemistry.
[78] J. Sample,et al. Protection from Interferon-Induced Apoptosis by Epstein-Barr Virus Small RNAs Is Not Mediated by Inhibition of PKR , 2005, Journal of Virology.
[79] M. Katze,et al. Molecular Mechanisms Responsible for Malignant Transformation by Regulatory and Catalytic Domain Variants of the Interferon-induced Enzyme RNA-dependent Protein Kinase (*) , 1995, The Journal of Biological Chemistry.
[80] U. Maitra,et al. Regulation of GTP hydrolysis prior to ribosomal AUG selection during eukaryotic translation initiation , 2005, The EMBO journal.
[81] Amer A. Beg,et al. Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.
[82] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[83] P. Romano,et al. Protein Synthesis and Endoplasmic Reticulum Stress Can Be Modulated by the Hepatitis C Virus Envelope Protein E2 through the Eukaryotic Initiation Factor 2α Kinase PERK , 2003, Journal of Virology.
[84] E. Domingo,et al. Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action , 2006, Microbiology and Molecular Biology Reviews.
[85] S. Zeuzem,et al. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa , 1997, Hepatology.
[86] Rekha C. Patel,et al. PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR* , 2000, The Journal of Biological Chemistry.
[87] A. Moreau,et al. Mutations within the Hepatitis C Virus Genotype 1b E2-PePHD Domain Do Not Correlate with Treatment Outcome , 2005, Journal of Clinical Microbiology.
[88] A. Shahangian,et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.
[89] Tsonwin Hai,et al. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. , 2001, Gene.
[90] E. Meurs,et al. The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex. , 2006, Cellular signalling.
[91] Ł. Kruszyna,et al. Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment. , 2006, Japanese journal of infectious diseases.
[92] H. Kawasaki,et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. , 1998, Cancer research.
[93] S. Kadereit,et al. Protein kinase PKR is required for platelet‐derived growth factor signaling of c‐fos gene expression via Erks and Stat3 , 2001, The EMBO journal.
[94] A. Hovanessian. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. , 1989, Journal of interferon research.
[95] M. Karin,et al. Double-stranded RNA-dependent Protein Kinase Phosphorylation of the α-Subunit of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis* , 2006, Journal of Biological Chemistry.
[96] M. Katze,et al. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[97] David Hawke,et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.
[98] D. Harrich,et al. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription , 2005, Virology Journal.
[99] M. Mathews,et al. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.
[100] C. D. Krause,et al. Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.
[101] A. Koromilas,et al. Dominant Negative Function by an Alternatively Spliced Form of the Interferon-inducible Protein Kinase PKR* , 2001, The Journal of Biological Chemistry.
[102] Jill K Thompson,et al. Role of IB Ubiquitination in Signal-induced Activation of NF-B in Vivo(*) , 1996, The Journal of Biological Chemistry.
[103] M. Coffey,et al. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus , 1998, The EMBO journal.
[104] M. Tohyama,et al. An RNA‐dependent protein kinase is involved in tunicamycin‐induced apoptosis and Alzheimer's disease , 2004, The EMBO journal.
[105] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[106] M. Serrano,et al. Antiviral action of the tumor suppressor ARF , 2006, The EMBO journal.
[107] Paola Fazi,et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.
[108] L. Tone,et al. A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia. , 2005, Blood cells, molecules & diseases.
[109] P. Lengyel. Tumor-suppressor genes: news about the interferon connection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[110] Tyson V. Sharp,et al. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. , 1998, Virology.
[111] M. Clemens,et al. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. , 1995, Experimental cell research.
[112] R. M. Marión,et al. Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. , 1999, Nucleic acids research.
[113] O. Elroy-Stein,et al. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.
[114] L. Beretta,et al. Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein , 2001, Oncogene.
[115] A. Heller,et al. Expression of a PKR dominant-negative mutant in myogenic cells interferes with the myogenic process. , 2000, Experimental cell research.
[116] Arvin C. Dar,et al. Higher-Order Substrate Recognition of eIF2α by the RNA-Dependent Protein Kinase PKR , 2005, Cell.
[117] K. Hunt,et al. Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[118] Stephen G Swisher,et al. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). , 2002, Cancer research.
[119] I. Mohr,et al. Identification of a Lytic-Cycle Epstein-Barr Virus Gene Product That Can Regulate PKR Activation , 2003, Journal of Virology.
[120] O. Jaillon,et al. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. , 1998, The Journal of general virology.
[121] K. Schappert,et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. , 1992, The EMBO journal.
[122] R. Kaufman,et al. Double-Stranded RNA-Activated Protein Kinase (PKR) Is Negatively Regulated by 60S Ribosomal Subunit Protein L18 , 1999, Molecular and Cellular Biology.
[123] J. Puglisi,et al. Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR. , 2006, Journal of molecular biology.
[124] A. Shatkin,et al. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. , 1997, Virology.
[125] L. David,et al. Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR* , 2003, Journal of Biological Chemistry.
[126] S. B. Lee,et al. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.
[127] P. Moore,et al. Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.
[128] K. Jeang,et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.
[129] J. Buchner,et al. Hsp90 & Co. - a holding for folding. , 1999, Trends in biochemical sciences.
[130] S. Nanduri,et al. 1H, 13C, 15N Resonance Assignment of the 20 kDa Double Stranded RNA Binding Domain of PKR , 1998, Journal of biomolecular NMR.
[131] B. Williams,et al. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR , 1999, Oncogene.
[132] A. Levitzki,et al. Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell death , 2005, Cancer biology & therapy.
[133] B. Williams,et al. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.
[134] N. Sonenberg,et al. Double-stranded RNA-dependent Protein Kinase Mediates c-Myc Suppression Induced by Type I Interferons* , 1996, The Journal of Biological Chemistry.
[135] M. Iordanov,et al. Two mechanisms of caspase 9 processing in double-stranded RNA- and virus-triggered apoptosis , 2005, Apoptosis.
[136] H. Nakano,et al. TRAF Family Proteins Link PKR with NF-κB Activation , 2004, Molecular and Cellular Biology.
[137] Arnab Ghosh,et al. Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions. , 2004, Archives of biochemistry and biophysics.
[138] M. Katze,et al. Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.
[139] W. Fujimoto,et al. Expression of Double‐Stranded RNA‐Activated Protein Kinase in Keratinocytes and Keratinocytic Neoplasia , 2003, The Journal of dermatology.
[140] M. Mathews,et al. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR , 2002, Oncogene.
[141] Mikhail Chernov,et al. Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .
[142] M. Katze,et al. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins , 1994, Molecular and cellular biology.
[143] E. Paoletti,et al. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses. , 1995, Virology.
[144] B. Williams,et al. NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase , 2000, Molecular and Cellular Biology.
[145] M. Esteban,et al. Caspase 9 activation by the dsRNA‐dependent protein kinase, PKR: molecular mechanism and relevance , 2002, FEBS letters.
[146] M. Esteban,et al. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. , 1997, Virology.
[147] M. Katze,et al. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[148] P. Romano,et al. Ribosome Targeting of PKR Is Mediated by Two Double-stranded RNA-binding Domains and Facilitates in Vivo Phosphorylation of Eukaryotic Initiation Factor-2* , 1997, The Journal of Biological Chemistry.
[149] A. Gobl,et al. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours. , 1998, European journal of cancer.
[150] J. Li,et al. Activation of the dsRNA-dependent kinase. , 1994, Progress in molecular and subcellular biology.
[151] S. Hasnain,et al. Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. , 2000, Biochemistry.
[152] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[153] I. Mohr,et al. Inhibition of PACT-Mediated Activation of PKR by the Herpes Simplex Virus Type 1 Us11 Protein , 2002, Journal of Virology.
[154] Tsonwin Hai,et al. Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis* , 2006, Journal of Biological Chemistry.
[155] M. Esteban,et al. The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. , 1993, Virology.
[156] J. Langland,et al. Reovirus σ3 Protein: dsRNA Binding and Inhibition of RNA-Activated Protein Kinase , 1998 .
[157] D. Purcell,et al. Two Dimerization Domains in the Trans-activation Response RNA-binding Protein (TRBP) Individually Reverse the Protein Kinase R Inhibition of HIV-1 Long Terminal Repeat Expression* , 2001, The Journal of Biological Chemistry.
[158] T. Haneji,et al. Okadaic acid induces tyrosine phosphorylation of IκBα that mediated by PKR pathway in human osteoblastic MG63 cells , 2005, Molecular and Cellular Biochemistry.
[159] M. Esteban,et al. Induction of Apoptosis by Double-Stranded-RNA-Dependent Protein Kinase (PKR) Involves the α Subunit of Eukaryotic Translation Initiation Factor 2 and NF-κB , 1999, Molecular and Cellular Biology.
[160] A. García-Sastre,et al. Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.
[161] C. Rivas,et al. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. , 1998, Virology.
[162] R. Silverman,et al. The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis , 1998, Cell Death and Differentiation.
[163] B. Williams. Signal Integration via PKR , 2001, Science's STKE.
[164] J. Nussbaum,et al. Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. , 2003, Cancer letters.
[165] J. Radosevich,et al. Interferon-Responsive Protein Kinase (p68) and Proliferating Cell Nuclear Antigen Are Inversely Distributed in Head and Neck Squamous Cell Carcinoma , 1997, Tumor Biology.
[166] A. Koromilas,et al. Functional Characterization of pkr Gene Products Expressed in Cells from Mice with a Targeted Deletion of the N terminus or C terminus Domain of PKR* , 2002, The Journal of Biological Chemistry.
[167] M. Katze,et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.
[168] A. Hovanessian,et al. Further characterization of the protein kinase activity mediated by interferon in mouse and human cells. , 1984, The Journal of biological chemistry.
[169] N. Sonenberg,et al. The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.
[170] O. Donzé,et al. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA‐dependent kinase PKR , 2001, The EMBO journal.
[171] M. Esteban,et al. Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. , 2003, The Journal of general virology.
[172] G. Peters,et al. Modular Structure of PACT: Distinct Domains for Binding and Activating PKR , 2001, Molecular and Cellular Biology.
[173] M. Esteban,et al. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-κB activation , 2001, Oncogene.
[174] M. Katze,et al. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. , 1995, Virology.
[175] C. Disteche,et al. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. , 1993, Genomics.
[176] O. Elroy-Stein,et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.
[177] E. Meurs,et al. PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.
[178] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[179] Adolfo Garcia-Sastre,et al. Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication , 2000, Journal of Virology.
[180] R. Kaufman,et al. Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR). , 1998, Biochemistry.
[181] G. Bagby,et al. The Anti-apoptotic Function of Hsp70 in the Interferon-inducible Double-stranded RNA-dependent Protein Kinase-mediated Death Signaling Pathway Requires the Fanconi Anemia Protein, FANCC* , 2002, The Journal of Biological Chemistry.
[182] O. Haus,et al. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer. , 2000, Archivum immunologiae et therapiae experimentalis.
[183] B. Roizman,et al. The γ134.5 Protein of Herpes Simplex Virus 1 Has the Structural and Functional Attributes of a Protein Phosphatase 1 Regulatory Subunit and Is Present in a High Molecular Weight Complex with the Enzyme in Infected Cells* , 1998, The Journal of Biological Chemistry.
[184] S. Goodbourn,et al. Double‐stranded RNA activates binding of NF‐kappa B to an inducible element in the human beta‐interferon promoter. , 1989, The EMBO journal.
[185] G. Sen,et al. PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.
[186] Arvin C. Dar,et al. Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.
[187] K. Endo,et al. Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. , 2000, Human pathology.
[188] W. Blalock,et al. Serine 18 Phosphorylation of RAX, the PKR Activator, Is Required for PKR Activation and Consequent Translation Inhibition* , 2004, Journal of Biological Chemistry.
[189] T. Mak,et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.
[190] M. Katze,et al. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. , 1989, European journal of biochemistry.
[191] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[192] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[193] M. Clemens. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. , 2006, The international journal of biochemistry & cell biology.
[194] A. Yoshimura,et al. Control of α Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2α) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2α-Dependent Gene Expression and Cell Death , 2004, Molecular and Cellular Biology.
[195] M. Katze,et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[196] S. Hanash,et al. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias. , 1996, Oncogene.
[197] N. McMillan,et al. Loss of PKR activity in chronic lymphocytic leukemia , 2004, International journal of cancer.
[198] P. Pitha,et al. Latently Expressed Human Herpesvirus 8-Encoded Interferon Regulatory Factor 2 Inhibits Double-Stranded RNA-Activated Protein Kinase , 2001, Journal of Virology.
[199] Aseem Kumar,et al. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[200] M. Esteban,et al. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors , 2000, Oncogene.
[201] I. Kerr,et al. Mechanism of Interferon Action: Inhibition of Viral Messenger Ribonucleic Acid Translation in L-Cell Extracts , 1972, Journal of virology.
[202] E. Park,et al. Double‐stranded RNA–activated protein kinase is required for the LPS‐induced activation of STAT1 inflammatory signaling in rat brain glial cells , 2005, Glia.
[203] R. Hayden,et al. Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[204] V. Pathak,et al. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs , 1989, Molecular and cellular biology.
[205] A. Cuddihy,et al. Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53 , 1999, Molecular and Cellular Biology.
[206] C. Rivas,et al. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. , 2003, The Journal of general virology.